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ABSTRACT
Objectives This paper presents the iterative process of 
participatory multistakeholder engagement that informed 
the development of a new national tuberculosis (TB) policy 
in Georgia, and the lessons learnt.
Methods Guided by realist evaluation methods, a 
multistakeholder dialogue was organised to elicit 
stakeholders’ assumptions on challenges and possible 
solutions for better TB control. Two participatory 
workshops were conducted with key actors, interspersed 
by reflection meetings within the research team and 
discussions with policymakers. Using concept mapping 
and causal mapping techniques, and drawing causal loop 
diagrams, we visualised how actors understood TB service 
provision challenges and the potential means by which a 
results- based financing (RBF) policy could address these.
Setting The study was conducted in Tbilisi, Georgia.
Participants A total of 64 key actors from the Ministry of 
Labour, Health and Social Affairs, staff of the Global Fund 
to Fight AIDS, TB and Malaria Georgia Project, the National 
Centre for Disease Control and Public Health, the National 
TB programme, TB service providers and members of the 
research team were involved in the workshops.
Results Findings showed that beyond provider incentives, 
additional policy components were necessary. These 
included broadening the incentive package to include 
institutional and organisational incentives, retraining 
service providers, clear redistribution of roles to support 
an integrated care model, and refinement of monitoring 
tools. Health system elements, such as effective referral 
systems and health information systems were highlighted 
as necessary for service improvement.
Conclusions Developing policies that address complex 
issues requires methods that facilitate linkages between 
multiple stakeholders and between theory and practice. 
Such participatory approaches can be informed by 
realist evaluation principles and visually facilitated by 
causal loop diagrams. This approach allowed us leverage 
stakeholders’ knowledge and expertise on TB service 
delivery and RBF to codesign a new policy.
INTRODUCTION
Although Georgia has made significant prog-
ress in controlling tuberculosis (TB), with 
reported success rates of 83% for new and 
relapsed TB cases, some challenges remain, 
including high rates of drug- resistant TB (DR- 
TB) (11% incidence in new patients and 31% 
in those previously treated) and relatively low 
cure rates for DR- TB.1 Following the collapse 
of the Soviet Union, several waves of health 
system reforms were implemented in Georgia 
from 1994 onwards. These led to a provid-
er–purchaser split whereby the Ministry of 
Labour, Health and Social Affairs (MoLHSA) 
took on the role of priority setting, policy 
formulation, programme development 
and funds allocation,2 while the actual TB 
programme delivery was relegated to private 
sector providers. During Soviet times, these 
functions were administered through the 
highly centralised Semashko system; health-
care personnel were employed by the state 
and were redistributed on a hierarchical basis 
at district, regional and republican levels. 
The system was tax- based with a guiding prin-
ciple of granting the population universal 
access to healthcare free of charge, although 
Strengths and limitations of this study
 ► Participation of a wide range of stakeholders provid-
ed a reality check to the initial plans of policymakers 
and the evaluation design of the researchers.
 ► Concept mapping and causal mapping strengthened 
the participatory process of policy formulation.
 ► Applying realist methodology further informed pol-
icymaking by stimulating a reflection on the influ-
ence of the policy context.
 ► A study limitation was the lack of inclusion of par-
ticipants without a biomedical or health programme 
background.
 ► Absence of consistency in attendees from the first 
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illegal out- of- pocket payments were extremely common.2 
In the aftermath of the Rose Revolution (2003–2007), 
healthcare delivery was further privatised and many 
disease control components were transferred to a diverse 
range of private providers, from small rural healthcare 
facilities to networks of healthcare services.3 Although 
the National TB programme remained responsible for 
policies, programmes, surveillance and monitoring, TB 
control and service delivery activities were effectively 
devolved to private providers.
In 2015, health authorities and TB control programme 
officials of Georgia, a country with 3.7 million inhabitants 
in the Caucasus region, initiated the process of devel-
oping a new policy to improve the performance of the 
TB control programme. Policymakers identified the poor 
integration of TB services at primary care level and low 
remuneration of service providers as barriers to effec-
tive care and treatment of TB patients.4 Reports of low 
coverage and poor adherence to treatment were also 
linked to low interest of private providers in sustaining 
TB service provision. Poor motivation of TB professionals 
further exacerbated the challenges.5 6 In response, 
through a concept note submitted to the Global Fund to 
Fight AIDS, TB and Malaria (GFATM), the Government 
of Georgia articulated its intention to pilot a results- 
based financing (RBF) scheme to motivate providers and 
improve TB service delivery in private settings.
Although the concept note indicated the Government’s 
readiness to test this new financing model, it provided 
little clarity on its design or on the evaluation model to be 
used. In response, in March 2017, the 4- year RBF for TB 
care (Results4TB) project was launched as a collaborative 
project between researchers and national policy makers. 
This Economic and Social Research Council/Medical 
Research Council/Department for International Devel-
opment/Wellcome Trust- funded project brings together 
policymakers, TB programme managers and national 
and international researchers to inform the policy formu-
lation, document and evaluate its implementation and 
assess its cost- effectiveness. The project intends to intro-
duce monetary incentives for health providers, rolled 
out alongside existing incentive schemes for patients, 
to improve medication adherence and as such improve 
treatment success rates for both drug- susceptible and 
multidrug- resistant TB patients.
The Results4TB project adopted a participatory, code-
sign approach to developing the study protocol that incor-
porates an impact evaluation, a cost- effectiveness analysis 
and a realist research component. We refer to Marchal et 
al7 for the protocol of the realist component, Chikovani et 
al for the trial protocol8 and to the project’s website9 for 
further information.
Since the publication of guidance on evaluation of 
complex interventions by the MRC in 2000 and of revised 
guidance in 2008,10 trial studies often include implemen-
tation fidelity evaluations, process evaluations and/or 
context mapping exercises. These are often adopted in 
trials in an effort to enhance understanding of the actual 
implementation processes and the influence of context on 
the observed outcomes.11 In 2015, the MRC issued guid-
ance on process evaluations of complex interventions,11 
which was followed by several studies that combined 
realist process evaluations with trials12–14, as well as by 
calls to go a step further and develop theory- informed 
trials.15 16 One innovation the Results4TB project pursues 
is to test how theory- informed trials can be designed and 
implemented.
Realist evaluation (RE) is a theory- based approach that 
is recognised for its usefulness in informing evidence- 
informed policy and practice.17 Based on a realist 
philosophy of science, it responds to a need for action-
able evidence for decision- making. Rather than merely 
confirming if policies and programmes work, realist 
inquiry identifies ‘what works in which circumstances and 
for whom?’.18 RE is increasingly used in the field of health 
policy and systems,19 for instance in the study of policy 
implementation,20 leadership and management,21 22 clin-
ical decision- making support,23 adherence to treatment,24 
and infection control.25
Besides including a realist research substudy, the 
Results4TB project adopted the RE perspective to inform 
the overall study design. A premise of the project is 
that this would have a number of advantages. First, the 
development of a detailed hypothesis in the form of an 
initial programme theory (IPT). The IPT can best be 
described as a detailed hypothesis that specifies which 
mechanisms a programme is expected to trigger among 
different groups of actors in order to achieve results. It 
also hypothesises the context conditions under which 
the programme would work. The IPT thus explains how 
the programme is expected to generate outcomes and in 
which conditions.18
In the case of Results4TB, we expected RE would stimu-
late researchers to develop a shared understanding of the 
policy, its objectives and the way it would work. This in turn 
would facilitate the integration of project sub- studies on its 
impact, cost- effectiveness and the underlying processes of 
implementation and evaluation, contribute to leaner data 
collection and a more integrated data analysis strategy.26 
Second, the RE approach can stimulate participation of 
key actors from the very start: eliciting the assumptions 
of the actors would both enrich the researchers’ under-
standing of the policy, and also establish strong links with 
the commissioners, designers, implementers and benefi-
ciaries of the new policy. This engagement would allow 
existing tacit actor knowledge, evidence and scientific 
analysis to feed into the policy formulation, leading to 
a realist formative process.27 Through these processes, 
critical issues and underdeveloped elements can be 
identified, leading to better intervention planning or 
implementation, and indirectly to better programme 
uptake.28 29 Such participatory processes can also help in 
better designing the evaluation by making the assumed 
causal pathways explicit and identifying potential inter-
mediate variables and interim outcomes that may help in 
monitoring proximal and distal outcomes.30 In the field 
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of theory- driven evaluation, group model building tech-
niques or other methods to jointly develop impact path-
ways or logic models are frequently used.31 32 To the best 
of our knowledge, there is little documentation of how 
such participatory processes are being applied in REs and 
perhaps even less for simultaneously informing policy 
formulation and evaluation design within the framework 
of a trial.
In this paper, we present the iterative process of partici-
patory multistakeholder engagement that we organised at 
the start of the project to elicit the IPT of the RBF policy. 
We also discuss the lessons learnt and compare our expe-
rience with other projects.
METHODS
The first step in any realist study is eliciting the IPT. There 
are generally three ways to elicit the programme theory 
(figure 1). First, in line with the participatory outlook of RE, 
the implicit assumptions of the key actors about how the 
programme is supposed to work can be unearthed. Under-
standing these assumptions is important since they influence 
the choices, design and implementation of a programme.18 
Second, literature reviews can be carried out to identify 
existing evidence, concepts and theories.29 Third, if there is 
no or little documented evidence, exploratory research can 
be carried out in lieu of a literature review.33
In this project, we elicited the assumptions of key actors 
regarding the problem of the ‘poor’ performance of the 
TB programme through a policy document review, concept 
mapping workshops and interviews with policymakers 
(figure 1).
Document review
We first collected and reviewed National TB Programme 
regulatory documents, the Strategic Plan for TB control 
for 2016–2020, TB programme guidelines, WHO mission 
reports and study reports on TB. The document review 
focused on the identification of key components of the 
existing TB control policy in Georgia, its objectives and 
beneficiaries and on how the TB programme operates 
throughout the country.34 This resulted in a preliminary 
root cause analysis of the problem.
Figure 1 Methods to develop the initial programme theory.
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First concept mapping workshop
We conducted two concept mapping workshops with key 
actors from the MoLHSA, staff of the GFATM Georgia 
Project, the National Centre for Disease Control and 
Public Health (NCDC), the National TB programme and 
with TB service providers. Participants were grouped in 
a way that ensured stakeholder representation, and that 
facilitated a ‘confrontation’ of different actors’ perspec-
tives (service managers, providers, programme managers, 
policymakers, researchers, representatives of funding 
agency).
In the first workshop, in May 2017, six members of the 
Georgian research team facilitated the group dialogues. 
Table 1 presents the background of the 31 participants.
Participants were taken through three steps: (1) identi-
fying the key elements of the problem (identification and 
analysis of the bottlenecks); (2) identifying the solutions 
(pathways of change) and (3) identifying the priorities 
for TB control. Figure 2 presents the conceptual frame-
work, adapted from Vassall et al,35 that was used to guide 
the group dialogues. Also see online supplemental file 1.
Interviews with key respondents
After the first workshop, we carried out unstructured 
interviews with nine key stakeholders, including poli-
cymakers, funders, implementers and programme 
managers involved in the policy formulation. The main 
objective was to validate the issues raised during the first 
workshop and to identify potential solutions. Although 
no formal interview guide was used, the facilitation 
probes from the first workshoponline supplemental file 
1 guided this informal inquiry (online supplemental 
file 1). Essentially, we aimed to explore their ideas and 
assumptions regarding different aspects of the policy. For 
example, on the need to improve collaboration between 
TB doctors and family doctors to encourage an integrated 
care approach, the distribution of roles in the proposed 
integrated care team, the policy verification system and 
the data availability for tracking process and outcome 
indicators.
Questions on TB and integration into primary health-
care (PHC) inquired on side effects and management 
of comorbidities—which have been raised as important 
issues affecting overall TB treatment care success rates. 
Respondents shed light on challenges to service inte-
gration, opportunities for improvement and the role of 
various actors at the different levels of care. Questions on 
intervention verification aimed to gain insight on existing 
health information systems collecting TB programmatic 
data, their weaknesses and opportunities for addressing 
these, including how to deter fraudulent practices within 
the system.
Due to the position of the respondents, interviews were 
not recorded nor systematically transcribed. Rather, notes 
were taken to inform the revision of the intervention 
description. Based on the information collected through 
these discussions, the intervention design was updated, 
documented, and later on presented to the second work-
shop participants for further discussion with a wider 
group of stakeholders.
The second workshop
The second workshop was organised in August 2017 
and was facilitated in the same manner (see online 
Figure 2 Conceptual framework (adapted from Vassall et al).35
P
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supplemental file 2). It was attended by 28 representatives 
and five research team members, split in two groups. Of 
those in attendance, five persons in each of the two groups 
had not attended the first workshop. These included 
a representative from the Social Service Agency (the 
State service purchaser under the MoLHSA) and family 
doctors and managers from primary care facilities (see 
table 1). During this workshop, participants were asked to 
analyse the main elements of the proposed new national 
TB policy—which had been redrafted after the first work-
shop, focusing on (1) the policy’s causal pathway, (2) the 
underlying processes of change (ie, mechanisms) and (3) 
the required context conditions.
Analytical strategy
After the first workshop, we organised a preliminary anal-
ysis meeting involving the research team, following which 
results from the workshop were summarised into tables. 
As mentioned above, we adopted a realist approach. RE 
offers the researcher a methodological approach that 
allows the discernment of how interventions work by 
exploring mechanisms underlying outcomes and the 
contextual conditions in which these occur. We used 
concept mapping and causal mapping techniques36 37 to 
analyse how the actors presented their understanding 
of the challenges of TB service provision and the poten-
tial mechanisms or means by which the policy could 
address these. Our exploration of mechanisms focused 
on those underlying the uptake of the policy by providers 
and managers, assuming that these two groups of stake-
holders would have a major influence on actual policy 
implementation. Both intrinsic and extrinsic motivation 
drivers were explored—the latter including remuner-
ation, staffing levels and general working conditions. 
‘Context’ was represented by facility- related factors (eg, 
scale, resource availability, geographical location, quality 
of care provided) and broader cultural and social factors. 
Results from the interviews and the document review 
were used to triangulate results of the workshop. The 
research team drew on their collective expertise in TB 
programmes, RBF, clinical care, the Georgian context 
and health systems. This analysis resulted in causal loop 
diagrams (CLD) structured to aid visualisation of the 
patient pathway for TB care within the health system 
(figure 2). These initial diagrams were reiteratively 
refined during extensive discussions within the research 
team and subsequently framed as an IPT (see results 
section).
After the second workshop, a similar process was 
carried out, leading to a refined CLD, a reformulated 
initial programme theory and a new policy package 
proposal (see results section). Figure 3 depicts the various 
processes that were combined to develop the IPT of the 
TB policy and the policy package proposal.
Patient and public involvement
Public engagement was critical to the redesign of the 
government policy to improve TB care, because it would 
give room for the issues experienced by various actors in 
the health system to be voiced and potentially addressed. 
While TB patients were not involved in the workshops, 
there was representation from civil society. The policy 
formulation workshops allowed for confrontation of 
perspectives between different actors including service 
managers, providers, programme managers, policy-
makers, researchers, representatives of funding agency 
without whose input there would not have been a revised 
and robust policy.
Data sharing agreement
No additional data available.
RESULTS
In this section, we present the results of the concept 
mapping workshops and interviews with key respondents, 
Figure 3 Stages of eliciting the initial programme theory and development of the policy package.
P
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and how these contributed to the formulation of the IPT 
and the policy package.
The first workshop
During this workshop, participants first identified the 
current bottlenecks and problems with the National 
TB programme. These included low patient awareness, 
which delays patients seeking care, the high cost of the 
first visit for patients if they are not properly referred by 
a family doctor, inappropriate management of the side- 
effects of the TB treatment and associated high costs, the 
complexity of the directly observed therapy regimen, as 
well as inadequate coordination between providers (ie, 
TB doctors and family physicians) for the management 
of comorbidities/side- effects and the efficient use of 
services covered under the Universal Health Coverage 
programme in this process (table 2)
In the second phase of the workshop, participants 
moved from bottleneck analysis to the identification of 
solutions they thought would need to be integrated in the 
new policy package. The following solutions were iden-
tified: better integration of TB care in general health 
services, training of first- line providers and specialists, 
institutional and team- based incentives instead of indi-
vidual incentives, better patient management informa-
tion systems and motivating poorly remunerated and 
ageing TB providers (table 2).
After the workshop, we identified the concepts 
mentioned or referred to by the participants in the 
discussions. We mapped these on the framework we 
adapted from Vassall et al35 (figure 2), adding the layer 
of ‘facility managers’ and ‘providers’. Next, we expanded 
this concept map into a CLD, which allowed us to identify 
context factors, potential negative effects and causal rela-
tions. Finally, we ‘pulled’ the diagram to a higher level of 
abstraction by grouping the causal loop nodes into the 
categories of policy, actors, context factors, outcomes 
and mechanisms. The resulting IPT indicated where 
the new policy would interact with the clinical pathway 
and how it could contribute to the TB programme 
outcomes of treatment success, treatment failure and 
loss to follow- up. Unsurprisingly perhaps, we found that 
the policy as proposed did not address any demand- side 
issues (figure 4).
The narrative version of the IPT is presented in box 1.
The results of the first workshop informed the policy 
formulation process at the national level. The Curatio 
International Foundation (CIF) team and international 
team members were involved in drafting the interven-
tion concept and held several meetings with repre-
sentatives of the NCDC and the MoLHSA. In essence, 
the research team argued that there was a need for a 
comprehensive package, including performance- based 
incentives for teams as opposed to incentivising only 
individual providers, a reallocation of roles and respon-
sibilities of healthcare providers (including family 
doctors) in the provision of TB care, the implemen-
tation of new tools (including patient management 
plans) and training for specialists on the management 
of side effects. These elements were taken into account 
by the policymakers. The inputs from the first workshop 
thus contributed to the formulation of a new TB policy 
package (figure 5).
Second workshop
At the start of this workshop, the CIF team presented 
the updated policy package, its objectives and the imple-
mentation modalities. The participants first discussed 
how they expected the policy would result in better TB 
control in the long term. To do so, they discussed the 
policy’s causal pathway, starting from components of the 
policy package and from the beneficiaries to expected 
effects and potential negative effects. Where opinions 
diverged, workshop facilitators stimulated further 
exploration of the issue. Participants proposed some 
modifications of the incentives package, for instance, 
calling for a refined bonus system. However, they did 
not challenge the main thrust of the proposed policy 
package.
In a second step, participants were asked to identify 
the mechanisms of change (ie, the processes that explain 
why a change would occur at the level of providers and 
patients, the healthcare facility or the health system), the 
essential conditions for the policy to succeed, the contex-
tual constraints and finally, the conditions necessary for a 
sustained effect. Box 2 presents the key points raised by 
the stakeholders.
The second workshop resulted in fine tuning the policy 
package (figure 6).
Table 2 Current bottlenecks and problems, and solutions proposed during the workshops
Current bottlenecks and problems Proposed solutions
Low patient awareness, contributing to which delays in seeking care.
High cost of the first visit for patients not referred by a family doctor.
Inappropriate management of the side- effects of the TB treatment 
and associated costs.
Complexity of the directly observed therapy regimen.
Inadequate coordination between providers for the management of 
comorbidities/side- effects.
Better integration of TB care in general health services.
Training of first- line providers and specialists.
Institutional and team- based incentives.
Better patient management information systems.
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Final analysis
In terms of research, the results from the second work-
shop were incorporated and mapped onto the initial CLD 
(figure 7). This exercise helped us in formulating a final 
version of the IPT (box 3).
Analysis from the second workshop also led to revision of 
some elements of the policy package following discussions 
with the policymakers. These included defining functions 
of each type of provider involved in the scheme, reporting 
requirements, distribution of bonus payment scheme 
between team members, monitoring and verification. The 
process was followed by corresponding changes to the 
design of the Results4TB pilot phase, the implementation 
manual and other supporting documents (eg, guidelines 
for Results4TB programme managers, reporting forms to 
the Social Service Agency, the patient management plan).
Figure 4 The initial programme theory resulting from the first workshop. TB, tuberculosis.
Box 1 Narrative version of the initial programme theory 
(first workshop)
 ► Incentives targeting the organisational level would incite service 
managers to increase the motivation of their providers, while train-
ing would improve the latter’s competences.
 ► Incentives for providers would increase their extrinsic motivation but 
could lead to crowding out their intrinsic motivation.
 ► All in all, a change of provider practices would occur, which in turn 
would affect how patients would take decisions regarding care for 
their health problem. Their decisions would also be influenced by 
context factors such as accessibility of the facility, and the accept-
ability and affordability of tuberculosis care.
 ► Potential negative effects include gaming, fraud and crowding out 
of intrinsic motivation, which would be influenced by the degree of 
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DISCUSSION
In this paper, we set out to report the process of eliciting 
the IPT of a new RBF policy that the Georgian author-
ities hope will address the persisting burden of TB in 
Georgia and improve service delivery. The Results4TB 
project took the opportunity of being asked to participate 
in the formulation and evaluation of the new policy to 
develop and implement a theory- informed trial design. 
Our assumption was that applying RE to the process from 
the very start would both contribute to develop a shared 
understanding of the policy among the researchers (and 
thus a theory- informed study design), and also allow us to 
identify the assumptions of the key actors, including the 
research team, and thus inform the policy package lever-
aging the strengths of diverse stakeholder perspectives.
The workshops proved helpful in informing the 
policy content and implementation design. The active 
involvement of key stakeholders allowed tacit knowl-
edge and expertise on TB service delivery and RBF from 
a range of stakeholders to be leveraged in codesigning 
the policy. Similar benefits of a participatory approach 
have been reported in health and non- health policy-
making processes.38 39 Similarly, the workshops allowed 
for a bottom- up problem analysis whereby participants 
working at operational level provided feedback based on 
their daily experience.38 Workshop participants indicated 
that beyond provider incentives, additional policy compo-
nents would be necessary to achieve desired goals. This 
included training of service providers to increase family 
doctors’ awareness on TB case detection, organising 
proper referral to TB services, better management of side- 
effects, a redistribution of roles between the PHC and TB 
specialised services and between care team members to 
support an integrated care model, training of integrated 
care team members on the principles of the new policy, 
creating a ‘patient card’ to increase patient involvement 
in TB care management and refinement of policy moni-
toring tools. These were issues not previously considered 
and could have led to programme failure if unaddressed.
To facilitate discussions during the first workshop, 
we adopted the patient pathway of Vassall et al,35 which 
proved useful in structuring the analysis. Participants 
were able to identify crucial issues which did not appear 
in the framework, including service organisation gaps, 
MoLHSA programme issues and social support—all 
factors impeding the delivery of TB care which the 
proposed policy would need to take into account.
CLDs were drawn with the aim of integrating findings 
from the workshops and the ideas of the researchers 
between the first and second workshops. We used CLDs 
to develop a graphical representation of the patient and 
health system pathways and the barriers and facilitators 
to the policy, more than to identify feedback loops as was 
done for instance by Renmans et al40 and Kwamie et al.22 
The CLDs demanded systematic in- depth discussions 
among the researchers and stimulated them to make their 
assumptions explicit, which has been mentioned as a key 
strength of CLD development.41 42 We also used the CLDs 
to identify key health system elements for successful TB 
care and used them to identify specific factors that would 
drive TB service integration at various levels. A similar 
use of CLDs was reported by Renmans et al.40 While we 
did not (yet) exploit the CLDs to their full potential, the 
CLD development ultimately contributed to developing a 
more refined IPT and gave a visual overview that all stake-
holders could appreciate and contribute to.
The research process we adopted is an example of 
embedded research. A senior researcher of the CIF team 
for instance played the dual role of being senior researcher, 
and a member of Parliament of Georgia and head of its 
Health and Social Issues Committee. Embedded research 
arguably facilitates the uptake of evidence in health poli-
cymaking.43 In our case, close interaction between policy-
makers and researchers helped both to refine the research 
design and also the actual policy. However, other factors 
Box 2 Summary of key points raised during the second 
workshop
 ► Every tuberculosis (TB) patient should be assigned to a primacy 
healthcare (PHC) facility with an integrated TB unit where the patient 
will receive general care from a family doctor as well as TB care by a 
TB specialist. While this could create geographical barriers for some 
patients, it would ensure an integrated approach.
 ► An integrated patient- centred TB care team should link patients to 
social services as needed.
 ► The role and functions of rural doctors should be well defined and 
different bonus payment schemes should be created for them.
 ► Incentives for family doctors should be a fixed top up to their salary 
as opposed to incentives per patient.
 ► Facilities with low numbers of patients need stronger incentives 
than facilities with a higher patient load.
 ► Managers of health facilities should ensure adequate service pro-
vision (eg, laboratory investigations, consultant visits) through 
contracts with other PHC facilities if they are unable to offer these 
services on site.
 ► The RBF policy and intervention should be incorporated as a compo-
nent of the National TB Programme.
 ► The TB state programme budget should be revised to ensure ad-
equate funding for routine tests and investigations. Mechanisms 
for distributing drugs to manage the side- effects of TB treatment 
should also be provided for within the TB programme’s budget.
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shaped the actual formulation of the policy. The work-
shops, for example, played a critical role in identifying 
existing challenges in TB care management throughout 
the patient pathway from a bottom- up perspective. The 
first workshop led to the ‘discovery’ of contextual factors 
influencing TB treatment outcomes that were unique 
and/or specific to the Georgian context and which we 
did not identify in the literature reviews. One such factor 
is the lack of information sharing between general and 
specialised TB service providers. The second workshop 
contributed to examining the operational constraints 
to a successful policy implementation (eg, difficulties 
to develop a monitoring system caused by the non- 
functional TB electronic reporting module) and propose 
appropriate solutions. Embedded research has a number 
of conditions of success including the need to have a flex-
ible approach and the ability to navigate contextual reali-
ties, including constraints.44
By taking a participatory approach, both workshops 
created an atmosphere where the inputs of all partic-
ipants were valued and acknowledged as critical for 
designing the new TB policy. This approach eventually 
resulted in the creation of a more context- adapted policy 
package. All critical feedback received during the work-
shops was later used by the research team to refine the 
policy concept which led to the various policy documents, 
including the programme component of the RBF pilot 
phase, the implementation manual and other supporting 
documents to facilitate a smooth policy introduction. 
The limited time allocated to group work during the 
workshops did not facilitate in- depth discussions on some 
topics, like the quality of the evidence provided by partic-
ipants to make a point.27
This study has some limitations. Ideally, both work-
shops would have been attended by the same partici-
pants to ensure continuity of the reflection. However, 
each workshop had slightly different objectives, and 
the results of the first workshop were presented at the 
start of the second one allowing for an additive process. 
We also took care to ensure that participants who were 
unavailable for the second workshop were replaced by 
representatives from the same category of stakeholders. 
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A second issue concerns the selection of stakeholders: 
while it was quite wide ranging in terms of including 
representatives from all levels of the health system, most 
attendees had a biomedical or health programme back-
ground with limited representation from the commu-
nity. We attempted to counter this professional bias by 
encouraging reflexion and critique, and used techniques 
to reduce group think as much as possible, for instance, 
always starting analysis with individual tasks, or by having 
facilitators challenging statements. In the next phases of 
the Results4TB programme, patient groups and commu-
nity representatives will be engaged prior to actual policy 
trial.
Further research into participatory policymaking could 
explore the conditions in which more inclusive participa-
tion occurs and the role herein of providing safe spaces 
for participants from different hierarchical levels to speak 
out, or of ensuring that all types of information and 
evidence are considered.
CONCLUSION
Developing policies that address complex issues, such 
as TB care in Georgia, and conducting policy research 
requires methods that facilitate the linkages between 
multiple stakeholders including researchers, and between 
theory and evidence on the one hand and practice on the 
other hand. Adopting a participatory approach to devel-
oping the IPT and the policy package, we found that the 
realist methodology helped us to leverage the tacit knowl-
edge and expertise on TB service delivery and RBF of a 
wide range of stakeholders to codesign the policy. The 
policy now reflects a more complex intervention, which 
will be tested using a combination of realist, trial and cost- 
effectiveness tools.
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Box 3 Narrative version of the reformulated initial 
programme theory
 ► Financial incentives will stimulate facili-
ty managers to (1) continue providing TB 
 services, (2) remit incentives to TB providers within their facilities 
and (3) optimise their TB service activities (mechanism of organi-
sational self- interest), on the condition that incentives are consid-
ered to be adequate and that sufficient monitoring and regulation 
systems are in place, in the absence of which gaming and fraud 
could occur.
 ► Incentives for providers will increase their extrinsic motivation 
(mechanism) and if the staffing and working conditions are ade-
quate (contextual prerequisite) they will contribute to better care for 
TB patients (outcome). Motivated and competent providers will pro-
vide better adherence support to patients, if supervision, monitoring 
and regulation are adequate. If not, crowding out of intrinsic motiva-
tion and gaming may occur (unintended consequence).
 ► Training for providers (eg, on side effect of drugs, management 
of comorbidities and patient- centred care as well as on how the 
RBF scheme will work) will enhance their competence, which 
leads to higher self- efficacy (mechanism). The latter, combined 
with an increase in extrinsic motivation, contributes to behaviour 
change, which will enable patients to better adhere to the treatment 
(outcome).
 ► TB patients who are informed, motivated and supported by provid-
ers, and trained to develop the needed skills, will initiate adherence 
if the social and cultural context is favourable (eg, absence of stig-
ma), if the facility is accessible, acceptable and affordable and if 
they consider the treatment regime as acceptable.
 ► The integration of TB care will improve the continuum of care be-
tween general and specialised TB services and thus facilitate the 
patient to correctly follow the treatment and care pathway towards 
being cured.
 ► TB patients who experience positive effects, feel capable of man-
aging their health condition (mechanism of self- efficacy) and feel 
in control of decisions about their care are more likely to maintain 
long- term adherence, on the condition that they consider the treat-
ment regime to be acceptable.
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